earnings
confidence high
sentiment negative
materiality 0.80
Select Medical Q2 net income falls 66% to $66.3M; EPS $0.43 vs $1.22
SELECT MEDICAL HOLDINGS CORP
2022-Q2 EPS reported
$0.79
revenue$3,184,288,000
- Revenue $1,584.7M (+1.3% YoY); net income $66.3M vs $196.2M; diluted EPS $0.43 vs $1.22.
- Adjusted EBITDA $181.0M vs $342.0M; includes $15.1M Provider Relief Fund income (prior year $98.0M).
- Critical illness recovery hospital segment Adjusted EBITDA plunged to $20.0M from $72.9M; margin 3.7% vs 13.4%.
- Board declared $0.125/share cash dividend payable Sept 2, 2022 to holders of record Aug 16, 2022.
- Reaffirms FY2022 revenue outlook $6.25B-$6.40B; defers Adjusted EBITDA/EPS guidance until labor market stabilizes.